SEC Form 4 · accession 0001611650-16-000003
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Pearce
Officer — CHIEF OPERATING OFFICER · Director
Period of report
Dec 31, 2015
Accepted (ET)
Mar 30, 2016 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WARRANTF1,F3 | $0.20 | Mar 28, 2016 | J | 1 | A | Mar 28, 2016 | Mar 28, 2021 | common stock | 1,000,000 | 1 | D |
Explanation of responses
- F1Warrant to purchase shares of common stock
- F2The warrant was issued in consideration for the extension of Mr. Pearce's employment contract.
- F3The Warrant may be exercised for up to 1 million shares of the Company's common stock